TherapeuticsMD, Inc.TXMDNASDAQ
Loading
Gross Profit Growth Recovery in ProgressRecovering
Percentile Rank50
5Y CAGR-30.9%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

5Y CAGR
-30.9%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
202435.25%
2023-98.10%
20225755.34%
2021-97.61%
202012.89%
2019224.15%
2018-5.51%
2017-6.79%
2016-2.98%
201537.71%